• COVID-19
• Research dataclose
• Other research productsclose
• HU close

LB

The spread of COVID-19 had radical impacts on the operation of higher education institutions. The University of Szeged, one of the leading universities in Hungary, Central Europe, adapted itself to the unprecedented pandemic situation in all its main pillars of operation: education, research, “third mission” activities, and high-quality medical care. Measures and actions included: transition to remote work, switch to online education, COVID-19 research projects, establishment of an epidemic hospital, H-UNCOVER nationwide screening, sustainability efforts and energy usage reduction. Thanks to conscious strategic planning, challenges could be handled efficiently, and quality performance was uninterrupted. Certain tools and practices are worth of consideration even in post-pandemic times as potential areas for development.

The purpose of the thesis is to analyze how the automotive manufacturing companies being active in Hungary operate in global value chains, with a particular focus on suppliers. Although the topic of GVC is widespread and discussed in international literature, there is a gap in relation to the Hungarian automotive manufacturing industry, especially in the current situation when the COVID-19 pandemic affects the operation of the multinational enterprises. The main identified research question is the following: What is the value creation of the automotive manufacturing industry in Hungary within global value chain? The research process started with a comprehensive literature review and theoretical background analysis about the GVC concept (including the introduction of ‘Smile-curve’) and FDI investment in Central and Eastern Europe (including the characterization of near-shoring activities) and continued with conducting a sample survey and semi-structured interviews with the key car parts suppliers. Executive board, managerial level and engineers were the target persons both for the survey and for interviews. Based on the literature review, I formulated two hypotheses: 1. The theory of ‘Smile curve’ is also valid in case of the Hungarian automotive manufacturing industry, typically low value-added production processes take place in the country. 2. In addition to the central location, the cheap and skilled Hungarian labour was the most important factor in the near-shoring activities of multinational companies expanding to Hungary. In order to be able to accept or reject the first hypothesis about the relevance of the so called ‘Smile curve’ in the Hungarian automotive manufacturing industry, to define position of the automotive manufacturer companies being active in Hungary in the global automotive manufacturing value chain and to create an in-depth understanding about investment incentives of the Western European firms in the country, I prepared an online survey. To test my second hypothesis about the reasons of near-shoring activity in Hungary, I conducted 3 interviews with industry experts from TIER 1 companies of different size. The targeted automotive parts manufacturers are all suppliers of the 5 OEMs present in Hungary (Audi, BMW, Mercedes, Opel and Suzuki) among others. The new results of the doctoral dissertation are the following: I can reject the first hypothesis about the relevance of ‘Smile curve’ in the Hungarian automotive manufacturing industry, because beside manufacturing activities with low added value typically, also research and development activities take place at bigger multinational companies with higher added value. I can accept the second hypothesis about near-shoring in Hungary, because beside the ‘proximity to export markets’, the cheap but skilled labour was decisive when multinationals decided to invest in the country. The ‘positive support system’, ‘favourable tax conditions’, ‘government policy’ and ‘proximity to HQ’ were aspects that companies used, but they are rather neutral factors. The ‘good infrastructure’ is not so good in the real life and the ‘cheap raw material’ is not cheap, because firms have to deal with world market prices, thus, these were not attractive to investors. Further results about the business operations of the analyzed supplier companies: The purchasing decisions for the Hungarian production happens locally decisively, either independently or with involving the headquarter. The manufactured products are typically drive chains, body parts and electric sensors and the proportion of products designated by OEMs is rather high. Western Europe is the biggest export market of the companies analysed, followed by China, North-America and the Central Eastern European region. Relocation processes are not characteristic of the firms. If so, only from other country to Hungary and it is also determined by OEMs providing new opportunities for them. In some cases, wage costs and logistics also play a role in the relocation process. Electromobility and autonomous driving are the most affecting trends in the automotive manufacturing industry. The semiconductor shortage as a serious downside risk is also the result of the pandemic. The effects of COVID-19 are becoming less pronounced today, but the semiconductor crisis is continuing. Favourable tax conditions and higher value added are the success criteria that will help the Hungarian automotive manufacturing industry to remain competitive in the future. Professional trainings, more support for SMEs and favourable legal conditions are also important aspects. Today, the CEE region, including Hungary is a net exporter of knowledge-intensive goods. To improve its global competitiveness and to be able to move into higher-value-added goods and services, the region should invest more in R&D, infrastructure, education and collaboration between companies and universities. The key players in the automotive part manufacturing has realized that value added is a very important factor in the success of an industry and it can be increased due to investment in research and development and innovation. As revealed by the research, they have already established R&D centers and joint projects with universities (e.g. departments), so companies are well on their way to producing higher added value.

Autophagy is an intracellular catabolic process that controls infections both directly and indirectly via its multifaceted effects on the innate and adaptive immune responses. It has been reported that LPS stimulates this cellular process, whereas the effect of IL-36α on autophagy remains largely unknown. We, therefore, investigated how IL-36α modulates the endogenous and LPS-induced autophagy in THP-1 cells. The levels of LC3B-II and autophagic flux were determined by western blotting. The intracellular localization of LC3B was measured by immunofluorescence assay. The activation levels of signaling pathways implicated in autophagy regulation were evaluated by using a phosphokinase array. Our results showed that combined IL-36α and LPS treatment cooperatively increased the levels of LC3B-II and Beclin-1, stimulated the autophagic flux, facilitated intracellular redistribution of LC3B, and increased the average number of autophagosomes per cell. The IL36α/LPS combined treatment increased phosphorylation of STAT5a/b, had minimal effect on the Akt/PRAS40/mTOR pathway, and reduced the levels of phospho-Yes, phospho-FAK, and phospho-WNK1. Thus, this cytokine/PAMP combination triggers pro-autophagic biased signaling by several mechanisms and thus cooperatively stimulates the autophagic cascade. An increased autophagic activity of innate immune cells simultaneously exposed to IL-36α and LPS may play an important role in the pathogenesis of Gram-negative bacterial infections. SARS-CoV-2 can infect and replicate in esophageal cells and enterocytes, leading to direct damage to the intestinal epithelium. The infection decreases the level of angiotensin converting enzyme 2 receptors, thereby altering the composition of the gut microbiota. SARS-CoV-2 elicits a cytokine storm, which contributes to gastrointestinal inflammation. The direct cytopathic effects of SARS-CoV-2, gut dysbiosis, and aberrant immune response result in increased intestinal permeability, which may exacerbate existing symptoms and worsen the prognosis. By exploring the elements of pathogenesis, several therapeutic options have emerged for the treatment of COVID-19 patients, such as biologics and biotherapeutic agents. However, the presence of SARS-CoV-2 in the feces may facilitate the spread of COVID-19 through fecal-oral transmission and contaminate the environment. Thus, gastrointestinal SARS-CoV-2 infection has important epidemiological significance. The development of new therapeutic and preventive options is necessary to treat and restrict the spread of this severe and widespread infection more effectively.